These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 1008546

  • 1. Effect of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on experimental herpes simplex keratitis.
    Kaufman HE, Varnell ED.
    Antimicrob Agents Chemother; 1976 Dec; 10(6):885-8. PubMed ID: 1008546
    [Abstract] [Full Text] [Related]

  • 2. Viral keratitis-inhibitory effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate.
    Sidwell RW, Allen LB, Huffman JH, Revankar GR, Robins RK, Tolman RL.
    Antimicrob Agents Chemother; 1975 Oct; 8(4):463-7. PubMed ID: 1190753
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of experimental deoxyribonucleic acid virus-induced encephalitis by 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate.
    Allen LB, Thompson JM, Huffman JH, Revankar GR, Tolman RL, Simon LN, Robins RK, Sidwell RW.
    Antimicrob Agents Chemother; 1975 Oct; 8(4):468-73. PubMed ID: 172008
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate in therapy of equine abortion virus-induced hepatitis in hamsters.
    Allen LB, Huffman JH, Revankar GR, Tolman RL, Simon LN, Robins RK, Sidwell RW.
    Antimicrob Agents Chemother; 1975 Oct; 8(4):474-8. PubMed ID: 172009
    [Abstract] [Full Text] [Related]

  • 5. Comparative efficacy of 5-methoxymethyl-2'-deoxyuridine, 9 beta-D-arabinofuranosyladenine and 5-iodo-2'-deoxyuridine in the treatment of experimental herpes simplex keratitis.
    Meldrum JB, Gupta VS, Babiuk LA.
    Chemotherapy; 1980 Oct; 26(1):54-63. PubMed ID: 7353440
    [Abstract] [Full Text] [Related]

  • 6. Ara AMP- a highly soluble new antiviral drug.
    Pavan-Langston D, North RD, Geary PA.
    Ann Ophthalmol; 1976 May; 8(5):571-9. PubMed ID: 937940
    [Abstract] [Full Text] [Related]

  • 7. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
    Falcon MG, Jones BR.
    J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039
    [Abstract] [Full Text] [Related]

  • 8. Effect of iontophoretic and topical application of antiviral agents in treatment of experimental HSV-1 keratitis in rabbits.
    Kwon BS, Gangarosa LP, Park NH, Hull DS, Fineberg E, Wiggins C, Hill JM.
    Invest Ophthalmol Vis Sci; 1979 Sep; 18(9):984-8. PubMed ID: 90030
    [Abstract] [Full Text] [Related]

  • 9. Therapy with 9-beta-D-arabinofuranosyladenine (ARA-A) and 2'-deoxycoformycin increases the ARA-A content of ocular tissues.
    O'Brien WJ.
    Curr Eye Res; 1986 Aug; 5(8):595-9. PubMed ID: 3489583
    [Abstract] [Full Text] [Related]

  • 10. Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
    O'Brien WJ, Taylor JL.
    Am J Med; 1982 Jul 20; 73(1A):294-9. PubMed ID: 6285720
    [Abstract] [Full Text] [Related]

  • 11. Anti-herpes activity of adenine arabinoside monophosphate.
    Trobe JD, Centifanto Y, Zam ZS, Varnell E, Kaufman HE.
    Invest Ophthalmol; 1976 Mar 20; 15(3):196-9. PubMed ID: 1254407
    [Abstract] [Full Text] [Related]

  • 12. Acyclic antimetabolite therapy of experimental herpes simplex keratitis.
    Pavan-Langston D, Campbell R, Lass J.
    Am J Ophthalmol; 1978 Nov 20; 86(5):618-23. PubMed ID: 213976
    [Abstract] [Full Text] [Related]

  • 13. Treatment of herpes simplex keratitis with idoxuridine and vidarabine: a double-blind study.
    Chin GN.
    Ann Ophthalmol; 1978 Sep 20; 10(9):1171-4. PubMed ID: 367239
    [Abstract] [Full Text] [Related]

  • 14. Antiviral agents in herpes simplex keratitis.
    Raju VK.
    Indian J Ophthalmol; 1982 Jul 20; 30(4):209-11. PubMed ID: 6820003
    [No Abstract] [Full Text] [Related]

  • 15. Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine.
    Smith SH, Shipman C, Drach JC.
    Cancer Res; 1978 Jul 20; 38(7):1916-21. PubMed ID: 207416
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and antiviral activity of certain 5'-monophosphates of 9-D-arabinofuranosyladenine and 9-D-arabinofuranosylhypoxanthine.
    Revankar GR, Huffman JH, Allen LB, Sidwell RW, Robins RK, Tolman RL.
    J Med Chem; 1975 Jul 20; 18(7):721-6. PubMed ID: 1171242
    [Abstract] [Full Text] [Related]

  • 17. Antiviral update.
    Kaufman HE.
    Ophthalmology; 1979 Jan 20; 86(1):131-6. PubMed ID: 119198
    [Abstract] [Full Text] [Related]

  • 18. Antiviral drugs for herpes simplex keratitis.
    Soll DB, Obrotka TM.
    Am Fam Physician; 1977 Dec 20; 16(6):116-7. PubMed ID: 412404
    [No Abstract] [Full Text] [Related]

  • 19. Use of nucleoside analogues in the treatment of herpes simplex virus eye diseases.
    Sundmacher R.
    Metab Pediatr Syst Ophthalmol; 1983 Dec 20; 7(2):89-94. PubMed ID: 6686278
    [Abstract] [Full Text] [Related]

  • 20. Herpes simplex keratitis: animal models to guide the selection and optimal delivery of antiviral chemotherapy.
    Falcon MG, Jones BR.
    J Antimicrob Chemother; 1977 Mar 20; 3 Suppl A():83-9. PubMed ID: 863807
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.